LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.42 | 17.25 | 31 | 3895 | 0.0080 | 0.0778 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.42 | 17.25 | 3355 | 3895 | 0.8612 | 0.9621 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.42 | 17.25 | 2 | 3895 | 0.0005 | -0.2409 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 44.42 | 17.25 | 4433 | 3895 | 1.1379 | 1.0333 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.39 | 17.25 | 41 | 4141 | 0.0099 | 0.1157 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.39 | 17.25 | 3682 | 4141 | 0.8890 | 0.9705 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.39 | 17.25 | 2 | 4141 | 0.0005 | -0.2385 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 46.39 | 17.25 | 4836 | 4141 | 1.1677 | 1.0396 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 48.36 | 17.25 | 54 | 4390 | 0.0123 | 0.1535 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 48.36 | 17.25 | 3951 | 4390 | 0.8999 | 0.9738 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 48.36 | 17.25 | 4 | 4390 | 0.0009 | -0.1672 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 48.36 | 17.25 | 5208 | 4390 | 1.1862 | 1.0432 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 50.33 | 17.25 | 49 | 4651 | 0.0105 | 0.1380 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 50.33 | 17.25 | 4223 | 4651 | 0.9080 | 0.9762 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 50.33 | 17.25 | 3 | 4651 | 0.0006 | -0.1948 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 50.33 | 17.25 | 5626 | 4651 | 1.2096 | 1.0477 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 52.30 | 17.25 | 66 | 4798 | 0.0138 | 0.1797 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 52.30 | 17.25 | 4510 | 4798 | 0.9399 | 0.9848 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 52.30 | 17.25 | 2 | 4798 | 0.0004 | -0.2331 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 52.30 | 17.25 | 6030 | 4798 | 1.2566 | 1.0571 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 54.27 | 17.25 | 111 | 4884 | 0.0227 | 0.2568 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 54.27 | 17.25 | 4833 | 4884 | 0.9895 | 0.9974 | MN20160310_N02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 54.27 | 17.25 | 5 | 4884 | 0.0010 | -0.1411 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 54.27 | 17.25 | 6421 | 4884 | 1.3147 | 1.0683 | MN20160310_N02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 56.24 | 17.25 | 153 | 4929 | 0.0310 | 0.3067 | MN20160310_N02 | E17 |